UBS: Europe is not the US when it comes to life sciences

While US life sciences markets cool, Europe’s policy support, talent inflows and stable demand create a resilient investment landscape, says Olafur Margeirsson, head of real estate, research and strategy, EMEA ex-DACH, at UBS.

PRIVATE REAL ESTATE

Register to unlock this content

• Daily global private real estate news and market intelligence
• Expertly curated insights to keep you ahead of the market
• Faster, data-driven decision-making powered by our AI interface, Ask PEI
• Access to proprietary research and reports
• Selected investor strategy and competitor performance data

Register nowFind out more

SponsoredEuropeNorth AmericaHuman CapitalSponsored